NEW YORK (TheStreet) -- WebMD Health (WBMD) shares are up 6.7% to $53.21 on Wednesday after being upgraded to "buy" from "hold" by analysts at Stifel Nicolaus (SF) with a $60 price target.
The firm cites increased ad revenue as the reason for the more optimistic outlook.
Must Read: Warren Buffett's 25 Favorite Stocks
TheStreet Ratings team rates WEBMD HEALTH CORP as a Hold with a ratings score of C. TheStreet Ratings Team has this to say about their recommendation:
"We rate WEBMD HEALTH CORP (WBMD) a HOLD. The primary factors that have impacted our rating are mixed - some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income and revenue growth. However, as a counter to these strengths, we also find weaknesses including weak operating cash flow and generally higher debt management risk."